Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

I-Mab Explores TJM2 in Treating Severe COVID-19 Disease

contractpharmaMarch 16, 2020

Tag: I-Mab Biopharma , COVID-19 , TJM2

PharmaSources Customer Service